KIMBERLEE BUNKARTAS: Open Payments
NPI 1093944738 · DERRY, NH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$279 in 13 payments from 5 companies in 2025. Trend: 2023 $103 · 2024 $197 · 2025 $279
Food & beverage: $279
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 6 | $140 |
| Novo Nordisk Inc | 3 | $61 |
| Amgen Inc. | 2 | $42 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $20 |
| GlaxoSmithKline, LLC. | 1 | $17 |
Products named: QULIPTA, UBRELVY, OTEZLA, Wegovy, Ozempic, JARDIANCE, SHINGRIX.
Industry payments across NH — which companies pay providers there.
